Renal denervation: a potential new treatment modality for polycystic ovary syndrome?
Authors:
- Markus P SchlaichMSMarkus P Schlaich
- Nora StraznickyNSNora Straznicky
- Mariee GrimaMGMariee Grima
- Carolina Ika-SariCICarolina Ika-Sari
- Tye DawoodTDTye Dawood
- Felix MahfoudFMFelix Mahfoud
- Elisabeth LambertELElisabeth Lambert
- Reena ChopraRCReena Chopra
- Flora SocratousFSFlora Socratous
- Sarah HennebrySHSarah Hennebry
- Nina EikelisNENina Eikelis
- Michael BöhmMBMichael Böhm
- 1 May 2011
- journal article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 29 (5) , 991-996
Abstract
Polycystic ovary syndrome (PCOS) is associated with sympathetic nervous system activation, insulin resistance, and blood pressure elevation. Renal nerve ablation has been demonstrated to reduce sympathetic outflow and improve blood pressure control. Here we report on the effects of renal denervation on hemodynamic, metabolic, and renal parameters in two obese PCOS patients with hypertension. Sympathetic nerve activity was assessed at baseline using microneurography and norepinephrine spillover measurements. Insulin sensitivity was assessed by euglycemic hyperinsulinemic clamp. Measurements of cystatin-C, creatinine clearance, and urinary albumin-creatinine ratio were also obtained. All measurements were repeated 3 months after bilateral renal denervation achieved via percutaneous endovascular radiofrequency ablation. Muscle sympathetic nerve activity and whole body norepinephrine spillover were substantially elevated at baseline in both patients by approximately 2.5–3-fold. Bilateral renal nerve ablation reduced both indices of sympathetic nerve activity. This was associated with moderate reductions in blood pressure and a substantial improvement in insulin sensitivity by approximately 17.5% in the absence of weight changes at 3-month follow-up. Glomerular hyperfiltration and urinary albumin excretion were also reduced. These findings corroborate the relevance of sympathetic activation in PCOS and suggest that renal denervation exerts beneficial effects not only on blood pressure control but also on insulin sensitivity, renal, and endocrine abnormalities characteristic of PCOS.Keywords
This publication has 23 references indexed in Scilit:
- Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespanBMC Medicine, 2010
- Renal Denervation as a Therapeutic Approach for HypertensionHypertension, 2009
- Integrating albuminuria and GFR in the assessment of diabetic nephropathyNature Reviews Nephrology, 2009
- Sympathetic Activation in Chronic Renal FailureJournal of the American Society of Nephrology, 2009
- Global burden of obesity in 2005 and projections to 2030International Journal of Obesity, 2008
- Sympathetic Augmentation in HypertensionHypertension, 2004
- Relation Between Cardiac Sympathetic Activity and Hypertensive Left Ventricular HypertrophyCirculation, 2003
- Activation of ovarian sympathetic nerves in polycystic ovary syndromeEndocrinology, 1993
- Reflex sympathetic activation induces acute insulin resistance in the human forearm.Hypertension, 1993
- Treatment of Polycystic Ovary Syndrome: An OverviewHormone Research, 1990